Statins are indicated for the prevention of heart disease and stroke in specific populations
the verdict
SUPPORTED
the evidence backs this
confidence 75/100
Extensive clinical trial evidence and guidelines establish that statins are indicated for the prevention of heart disease and stroke in specific populations, particularly those at elevated cardiovascular risk.
Evidence for · 3
Sources of Heterogeneity in the Efficacy of Statins for Primary Prevention of Cardiovascular Diseases: A Systematic Review with Meta-Regression and Meta-Analysis of Within-Study Subgroup Differences.
2026 · cited by 0
This systematic review and meta-analysis of randomized controlled trials confirms that statin treatment significantly reduces major adverse cardiovascular events, myocardial infarction, and stroke in populations without prior cardiovascular disease.
See more details
More for · 2
Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.
2026 · cited by 0
This study identifies statins as foundational, low-cost generic agents that provide robust mortality benefits and form the basis of cardiovascular prevention protocols.
Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.
2026 · cited by 0
This review highlights that statins remain the foundation of lipid management because they lower LDL-C and prevent cardiovascular events in recommended populations.